Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1123724
Abstract: The formation of a robust long-term antigen (Ag)-specific memory, both humoral and cell-mediated, is created following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination. Here, by using polychromatic flow cytometry and complex data… read more here.
Keywords: heterologous vaccination; vaccination; cov specific; characterization sars ... See more keywords
Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2025.1596265
Abstract: Introduction Melioidosis is a major cause of disease and mortality in endemic tropical regions, and the etiologic agent, Burkholderia pseudomallei, is being isolated increasingly from an expanded range of environmental and clinical sources in locations… read more here.
Keywords: disease; comparison homologous; homologous heterologous; heterologous vaccination ... See more keywords
Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein
Sign Up to like & getrecommendations! Published in 2025 at "Viruses"
DOI: 10.3390/v17081095
Abstract: Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a highly pathogenic bunyavirus with a high case-fatality ratio for which there is no approved vaccine. Studies have assessed different vaccine technologies. However, few studies have… read more here.
Keywords: sftsv; vaccination regimens; homologous heterologous; immunization ... See more keywords